The overexpression of METTL3 significantly inhibited AML‐MSC adipogenesis (Fig. 4A,B) and increased the sensitivity of co‐cultured AML cells to chemotherapy (Fig. 4C). This evidence concerns the gene METTL3 and acute myeloid leukemia.